Table 1.
BRAF and PTEN variants identified by the Myriapod® NGS-IL 56G Onco Panel in PT#1 and PT#2.
| Allele variant | PT#1 | PT#2sk | PT#2ov | PT#2br |
|---|---|---|---|---|
| BRAF c.1802A>T | 48.72% | 24.42% | 58.74% | 58.71% |
| (1,899/1,804) | (2,522/815) | (2,823/4,019) | (6,163/8,764) | |
| BRAF c.1800G>A | 49.04% | 24.67% | 58.79% | 58.73% |
| (1,879/1,808) | (2,519/825) | (2,817/4,018) | (6,161/8,766) | |
| BRAF c.1799T>A | 48.98% | 24.54% | 58.78% | 58.71% |
| (1,881/1,806) | (2,519/819) | (2,816/4,016) | (6,161/8,760) | |
| PTEN c.165-2A>G | Absent | Absent | 76.1% | 71.22% |
| splice_acceptor_variant&intron_variant | (822/2,618) | (1,154/2,856) |